FBInvestor
Stocks / Collegium Pharmaceutical Inc
Institutional Ownership

Collegium Pharmaceutical Inc

CUSIP 19459J104COMCOLLQ1 2026

13D / 13G Filings
48
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
17.7%
Max % of class reported
Institutional Holders
258
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

48 filings · latest Feb 13, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 13, 2026Eventide Asset Management, LLC13G/A5.9%SEC
2Feb 13, 2026Rubric Capital Management LP13G/A4.7%1.50MSEC
3Nov 13, 2025Renaissance Technologies LLC13G5.1%1.60MSEC
4Aug 13, 2025Renaissance Technologies LLC13G/A4.8%1.52MSEC
5Aug 11, 2025Principal Global Investors13G/A4.6%1.47MSEC
6Aug 7, 2025Invesco Ltd.13G/A4.9%1.58MSEC
7May 14, 2025Rubric Capital Management LP13G/A9.3%3.00MSEC
8May 2, 2025Pacer Us Small Cap Cash Cows ETF13G/A1.1%419.1KSEC
9May 2, 2025Pacer Us Small Cap Cash Cows ETF13G5.4%2.14MSEC
10Apr 28, 2025Blackrock, Inc.13G/A15.6%5.00MSEC

38 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Collegium Pharmaceutical Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →